Key statistics
As of last trade, Biontech SE (22UA:FRA) traded at 90.00, 26.76% above the 52 week low of 71.00 set on Apr 07, 2025.
52-week range
| Open | 91.50 |
|---|---|
| High | 91.50 |
| Low | 90.00 |
| Bid | 89.50 |
| Offer | 90.45 |
| Previous close | 92.10 |
| Average volume | 15.62k |
|---|---|
| Shares outstanding | 259.03m |
| Free float | 233.52m |
| P/E (TTM) | -- |
| Market cap | 27.84bn USD |
| EPS (TTM) | -2.75 USD |
Data delayed at least 15 minutes, as of Mar 03 2026 08:57 GMT.
More ▼
- EQS-News: BIO-Europe Spring® 2026 Charts the Future of Life Sciences from Lisbon’s Shores
- BioNTech veröffentlicht am 10. März 2026 Ergebnisse für das vierte Quartal und das Geschäftsjahr 2025 und informiert über operativen Fortschritt
- BioNTech to Report Fourth Quarter and Full Year 2025 Financial Results and Corporate Update on March 10, 2026
- BioNTech Announces Appointment of Kylie Jimenez to Management Board as Chief People Officer
- BioNTech ernennt Kylie Jimenez zur neuen Personalvorständin
- J.P. Morgan Healthcare Conference: signals for a re-rating of the sector are gaining momentum
- BioNTech Provides Strategic Business Update and Outlines 2026 Areas of Focus at 44th Annual J.P. Morgan Healthcare Conference
- BioNTech präsentiert auf der 44. J.P. Morgan Healthcare-Konferenz Updates zur Geschäftsentwicklung und Schwerpunkte für das Jahr 2026
- BioNTech schließt Übernahme von CureVac N.V. samt damit verbundener Nachangebotsfrist ab und stärkt so die einzigartige Position im mRNA-Feld
- BioNTech Closes Acquisition of CureVac N.V. Including Subsequent Offering Period to Strengthen its Unique Position in the mRNA Field
More ▼
